Growth hormone therapy in Prader-Willi syndrome

International Journal of Obesity

Volumn 25, Issue 1, 2001, Pages 2-7

  Davies, P S W ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

BEHAVIOR; BODY GROWTH; CLINICAL FEATURE; DRUG EFFECT; ENDURANCE; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; MUSCLE FUNCTION; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

BODY COMPOSITION; CHILD; CHILD BEHAVIOR; GROWTH; HUMAN GROWTH HORMONE; HUMANS; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; PHYSICAL FITNESS; PRADER-WILLI SYNDROME; RISK FACTORS;

EID: 0035122413     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801518     Document Type: Review

References (32)

1. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartingem zustand imneugeborenenalter
2. Prader-Willi syndrome: Consensus diagnostic criteria
3. High resolution chromosome analysis and fluorescence in situ hybridization in patients referred for Prader-Willi or Angelman syndrome
4. Peculiar body composition in patients with Prader-Labhart-Willi syndrome
5. GH secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome
6. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhart-Willi syndrome
7. Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome
8. Impaired growth hormone responses to growth hormone releasing factor in obesity
9. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency
10. The growth hormone response to hexarelin in patients with Prader-Willi syndrome
11. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome
12. Effects of human growth hormone on levels of blood and urinary carbohydrate and fat metabolites in man
13. Growth hormone restores protein synthesis in skeletal muscle of old male rats
14. Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment
15. Changes in body composition and energy expenditure after six weeks growth hormone treatment
16. Growth hormone treatment of short stature in Prader-Willi syndrome
17. Growth hormone (GH) therapy in Prader-Willi syndrome children with neuro-secretory GH deficiency
18. Effects of growth hormone in Prader-Willi syndrome
19. One year results of growth hormone treatment of short stature in Prader-Willi Syndrome
20. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance
21. The effect of growth hormone on height, weight and body composition in children with Prader-Willi syndrome
22. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably
23. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study
24. The effect of growth hormone on behaviour in children with Prader-Willi syndrome
25. Growth hormone treatment of patients with Prader-Willi syndrome
26. Risk of leukemia after treatment with pituitary growth hormone
27. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy
28. Growth hormone treatment of children with Prader-Willi syndrome: Effects on glucose and insulin homeostasis
29. Five years of growth hormone treatment in children with Prader-Willi syndrome
30. Ethical issues in emerging new treatments such as growth hormone therapy for children with Down Syndrome and Prader-Willi syndrome